Table 3. Concentration of soluble ST2 and N-terminal pro-brain natriuretic peptide (NT-proBNP) in the patients hospitalized for myocardial infarction.

Variable	Control (N=30)	Favorable outcomes of MI (N=58)		Unfavorable outcomes of MI (N = 30)
		1st day	12th day	1st day	12th day
sST2 (ng/mL)	18.81 (15.12;21.03)	35.45 (24.44;53.79)*	17.00 (14.78;20.84)†	69.99 (45.87;216.20)*,‡	20.20 (16.47;39.78)†
NT-proBNP (fmol/mL)	8.23 (5.61;11.12)	33.45 (24.34;55.38)*	26.35 (16.68;67.76)	56.14 (19.03;187.90)*,†	41.66 (17.65;161.65)

Values are presented as median (25%:75% quartile).

^*Compared with the control group (P<0.05); ^†Statistically significant differences between groups at day 12 (P<0.05); ^‡Statistically significant differences in the variables between patients with favorable and unfavorable outcomes (P<0.05).